Dimensional Fund Advisors LP Immuno Precise Antibodies Ltd. Transaction History

Dimensional Fund Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$1.11 - $2.3 $4,122 - $8,542	-3,714 Reduced 23.32%	12,213 $20,000
Q3 2023 Nov 09, 2023	SELL	$1.76 - $3.04 $19,027 - $32,865	-10,811 Reduced 40.43%	15,927 $29,000
Q2 2023 Aug 09, 2023	SELL	$2.42 - $4.04 $4,631 - $7,732	-1,914 Reduced 6.68%	26,738 $79,000
Q1 2023 May 12, 2023	BUY	$2.77 - $5.49 $2,745 - $5,440	991 Added 3.58%	28,652 $79,000
Q4 2022 Feb 09, 2023	BUY	$4.5 - $5.72 $13,896 - $17,663	3,088 Added 12.57%	27,661 $144,000
Q3 2022 Nov 10, 2022	BUY	$3.77 - $6.39 $34,717 - $58,845	9,209 Added 59.94%	24,573 $98,000
Q2 2022 Aug 12, 2022	BUY	$3.8 - $6.08 $8,553 - $13,686	2,251 Added 17.17%	15,364 $59,000
Q1 2022 May 13, 2022	BUY	$3.64 - $6.49 $47,731 - $85,103	13,113 New	13,113 $67,000
Q3 2021 Nov 12, 2021	SELL	$5.14 - $13.22 $64,445 - $165,752	-12,538 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.02 - $12.91 $75,478 - $161,865	12,538 New	12,538 $75,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $10.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.